Jinmao Property Services Stock (OTC: JPPSF)

Latest news for Jinmao Property Services (OTC:JPPSF) Stock

Jinmao Property Services Co Ltd is a fast growing property management company in China, and a city operation service provider, managing a diversified property portfolio covering both residential properties and non-residential services.

JINMAO PPTY SVCS CO LTD by JINMAO PPTY SVCS CO LTD PCL.

Jinmao Property Services Co Ltd

Earnings

News

Toyota Motors Q1 2025 Revenue $77,336M

HC Wainwright &amp; Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGTX#NASDAQ">CGTX</a>) with a Buy and lowers the price target from $10 to $7.

Price Target

Analyst Ratings

CGTX

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $7

Significant industry capacity increases together with ancillary pricing changes in the competitive environment are making it difficult to drive increased yields. In addition, the Company has eliminated charging for change and cancellation fees which is expected to be a headwind to revenue per passenger segment on a year over year basis for at least the remainder of 2024.
On July 19, 2024, the company canceled 470 flights as a result of the crowdstrike it outage. 
The company estimates the negative impact to third quarter operating income related to this operational disruption was $7.2 million, primarily due to lost revenue.

Guidance

SAVE

Spirit Airlines Expects Q3 Total Revenue Of $1.155B - $1.175B, Est $1.331B

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) with a Buy and maintains $8 price target.

Reiteration

PCSA

HC Wainwright & Co. Reiterates Buy on Processa Pharma, Maintains $8 Price Target

WIIM

UDMY

Udemy shares are trading lower after the company issued weak Q3 guidance.

TDOC

Teladoc shares are trading lower after the company reported a Q2 revenue miss and withdrew its full year financial outlook for its consolidated operations and its BetterHealth segment.

Ecovyst (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECVT#NYSE">ECVT</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.13 by 7.69 percent. This is a 58.62 percent decrease over earnings of $0.29 per share from the same period last year. The company reported quarterly sales of $182.800 million which missed the analyst consensus estimate of $189.788 million by 3.68 percent. This is a 0.71 percent decrease over sales of $184.100 million the same period last year.

Earnings Misses

ECVT

Ecovyst Q2 2024 Adj. EPS $0.12 Misses $0.13 Estimate, Sales $182.800M Miss $189.788M Estimate

Financial&nbsp;Guidance
The Company is reaffirming its 2024 full year CAFD&nbsp;guidance&nbsp;of&nbsp;$395 million. The Company&#39;s 2024 financial&nbsp;guidance&nbsp;factors in the contribution of committed growth investments based on current expected closing timelines and estimates for merchant energy gross margin at the conventional fleet. 2024 CAFD&nbsp;guidance&nbsp;does not factor in the timing of when CAFD is realized from new growth investments pursuant to 5-year averages beyond 2024. Financial&nbsp;guidance&nbsp;is based on median renewable energy production estimates for the full year.

CWEN

Clearway Energy Reaffirms Its 2024 CAFD Outlook Of $395M

Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.52 by 25 percent. This is a 18.18 percent increase over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $10.89 billion which beat the analyst consensus estimate of $10.56 billion by 3.13 percent. This is a 19.62 percent increase over sales of $9.11 billion the same period last year.

Cenovus Energy Q2 EPS $0.39 Misses $0.52 Estimate, Sales $10.89B Beat $10.56B Estimate

<a href="https://www.infosys.com/" target="_blank">Infosys</a>&nbsp;(NSE: INFY) (BSE: INFY) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>), a global leader in next-generation digital services and consulting, today announced an expanded strategic collaboration with&nbsp;<a href="https://www.servicenow.com/" target="_blank">ServiceNow</a>&nbsp;to provide end-to-end managed services, leveraging AI capabilities of the&nbsp;<a href="https://www.servicenow.com/now-platform.html" target="_blank">Now Platform</a>&nbsp;and the&nbsp;<a href="https://www.infosys.com/services/experience-transformation/service-offerings/enterprise-service-management-cafe.html" target="_blank">Infosys Enterprise Service Management Caf&eacute; (ESM Caf&eacute;)</a>&nbsp;for enterprise business transformation.
<img alt="Infosys_Logo" src="https://mma.prnewswire.com/media/633365/4364085/Infosys_Logo.jpg" />
As part of this engagement, Infosys will aim to accelerate the ServiceNow implementation for enterprises such as&nbsp;<a href="https://www.bankfab.com/en-ae/personal" target="_blank">First Abu Dhabi Bank (FAB)</a>, by almost 30 to&nbsp;40 percent, allowing faster time-to-value &ndash; and also deliver a comprehensive suite of services and solutions. These include licenses, services, and implementation of the Infosys ESM Caf&eacute;, an AI-powered plug-and-play solution, part of&nbsp;<a href="https://www.infosys.com/services/cloud-cobalt.html" target="_blank">Infosys Cobalt</a>,&nbsp;a set of services, solutions and platforms for enterprises to accelerate their cloud journey. The Infosys ESM Caf&eacute; offers more than 70 applications covering various modules and ServiceNow capabilities, including AI and sustainable digital solutions.

INFY

Infosys and ServiceNow Team Up to Boost Business Transformation with AI

HC Wainwright &amp; Co. analyst Robert Burns reiterates BioNTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>) with a Buy and maintains $113 price target.

BNTX

HC Wainwright & Co. Reiterates Buy on BioNTech, Maintains $113 Price Target

Rush Street Interactive shares are trading higher after the company reported better-than-expected Q2 earnings and raised its FY24 revenue guidance.

Quarterly Dividend&nbsp;&nbsp;
On August&nbsp;1, 2024, Clearway Energy, Inc.&#39;s Board of Directors declared a quarterly dividend on Class A and Class C common stock of&nbsp;$0.4171&nbsp;per share payable on September&nbsp;16, 2024, to stockholders of record as of September&nbsp;3, 2024
<ul>
<li>Increasing the quarterly dividend by&nbsp;1.7%&nbsp;to&nbsp;$0.4171&nbsp;per share in the&nbsp;third quarter&nbsp;of 2024, or&nbsp;$1.6684&nbsp;per share annualized</li>
</ul>

Dividends

Clearway Energy Increases The Quarterly Dividend By 1.7% To $0.4171 Per Share, Payable September 16, 2024

Management expects revenues in the&nbsp;third quarter&nbsp;of 2024 between&nbsp;$107-110 million, representing a&nbsp;35%&nbsp;mid-point increase over the&nbsp;third quarter&nbsp;of 2023. Given the significant visibility and strong ongoing order flow, continued sequential growth is expected into the&nbsp;fourth quarter.

CAMT

Camtek Expects Q3 Revenue Of $107M-$110M, Est $104.014M

Perimeter Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRM#NYSE">PRM</a>) reported quarterly earnings of $0.14 per share. This is a 54.84 percent decrease over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $127.276 million which beat the analyst consensus estimate of $87.520 million by 45.43 percent. This is a 67.17 percent increase over sales of $76.137 million the same period last year.

Earnings Beats

Perimeter Solutions Q2 2024 GAAP EPS $0.14 Down From $0.31 YoY, Sales $127.276M Beat $87.520M Estimate

HC Wainwright &amp; Co. analyst Robert Burns reiterates Macrogenics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) with a Neutral and maintains $4 price target.

MGNX

HC Wainwright & Co. Reiterates Neutral on Macrogenics, Maintains $4 Price Target

Clearway Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>) reported quarterly earnings of $0.43 per share. This is a 30.3 percent increase over earnings of $0.33 per share from the same period last year. The company reported $366.00 million in sales this quarter. This is a 9.85 percent decrease over sales of $406.00 million the same period last year.

Clearway Energy Q2 EPS $0.43 Up From $0.33 YoY, Sales $366.00M Down From $406.00M YoY

Large Cap

Health Care

General

Cigna Reaffirms Fiscal Year 2024 Adjusted Revenues Of At Least $235B Versus Consensus Of $235.51B, With Adjusted EPS Of Guidance Of At Least $28.40 Versus Consensus Of $28.50

Camtek (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.64 by 3.13 percent. This is a 43.48 percent increase over earnings of $0.46 per share from the same period last year. The company reported quarterly sales of $102.591 million which beat the analyst consensus estimate of $101.274 million by 1.30 percent. This is a 39.09 percent increase over sales of $73.758 million the same period last year.

Camtek Q2 2024 Adj. EPS $0.66 Beats $0.64 Estimate, Sales $102.591M Beat $101.274M Estimate

HC Wainwright &amp; Co. analyst Robert Burns reiterates Kronos Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>) with a Buy and maintains $2.25 price target.

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Jinmao Property Services

News

Latest news for Jinmao Property Services (OTC:JPPSF) Stock